64 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
. Neither the Company nor any Subsidiary has received notice of any investigation or proceedings which, if decided adversely to the Company … knowledge, threatened administrative, regulatory or judicial action, claim or notice of noncompliance or violation, investigation or proceedings
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction … such further inquiry or investigation into such facts or matters as it may see fit.
(h) The Trustee shall not be deemed to have notice of any Default
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
or investigation pending or, to the Company’s Knowledge, threatened against or affecting the Company, or any of its properties before or by any court … , court costs and reasonable attorneys’ fees and costs of investigation.
“Marketed Underwritten Offering” has the meaning assigned to such term
8-K
EX-10.2
4trzs8ie
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
wtl4is 7v9tv0r3bla
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
dm09lyw0
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
0b8jk9i dr
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
mas l4lkhvtmqlg7dha
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.2
frdybk0b np9ol
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.1
z22ucw3rq4
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
ztold17rxrshi
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-4.2
1tkgvm38gdqyzksi9cu4
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.1
fxiqw7wv726j39m07rw
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-1.1
t3hufv
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
xxv2wdeovgzn
30 Mar 22
Prospectus supplement for primary offering
5:21pm